TG Therapeutics Inc. Stock
TG Therapeutics Inc. Stock
A very strong showing by TG Therapeutics Inc. today, with an increase of €2.86 (11.490%) compared to yesterday's price.
Our community is currently high on TG Therapeutics Inc. with 5 Buy predictions and 0 Sell predictions.
With a target price of 44 € there is a hugely positive potential of 61.14% for TG Therapeutics Inc. compared to the current price of 27.31 €.
So far the community has only identified positive things for TG Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | 11.490% | -0.975% | 4.602% | -33.680% | -4.251% | 78.040% | -37.067% |
| Heron Therapeutics Inc. | -3.960% | -9.054% | -19.476% | -63.319% | -29.668% | -64.362% | -94.461% |
| Evolus Inc | 0.000% | -4.783% | 23.034% | -63.193% | -19.633% | -44.204% | -57.164% |
| Sangamo Therapeutics Inc. | 1.350% | -5.478% | -2.575% | -63.362% | -4.803% | -83.604% | -96.557% |
Comments
TG Therapeutics (NASDAQ:TGTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $49.00 to $46.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $49.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat